Stockholm, Sweden
Arex Advisor AB are pleased to announce that Anna Ravnefjord joins the company as Regulatory Affairs Expert. Anna brings a wealth of experience in global Regulatory Affairs, with a particular focus on clinical development. Her proficiency extends to strategy work in several development phases, as well as complex regulatory environments in pharma and biotech. She also has exceptional competence in scientific advice and CTAs/INDs in the EU, US and UK.
“Anna’s extensive experience, coupled with her proven track record in navigating the complex environments of clinical development and regulatory interactions, perfectly aligns with our mission to support innovation in life science and deliver service solutions that contribute to successful outcomes” says Linda Thunell, CEO Arex Advisor.
Prior to joining Arex Advisor, Anna held a position as Associate Director Regulatory Affairs at AstraZeneca, working with a wide spectrum of product types such as small molecules, mAb, modRNA, ASO and ATMP (cell therapy). Her work in pre-clinical research has been recognised through several scientific publications.
The recruitment of Anna underscores Arex Advisor’s commitment to meet the ever-evolving needs of the life science industry. Anna will be based in Gothenburg.
About us: Arex Advisor offers strategic advice and operational support in pharmaceutical research and business development for pharma and bio-tech. Our mission is to help leaders and companies realise projects and reach goals. We are passionate about the successful processes, from development to commercialisation, of important medicines – which ultimately contribute to improving the lives of patients.
Contact:
Linda Thunell
